Acute leukemia in polycythemia vera


Published: June 16, 2009
Abstract Views: 189
PDF: 814
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

The clinical course of Polycythemia Vera (PV) is characterized by significant thrombohemorrhagic complications and variable risk for disease transformation into myeloid metaplasia with myelofibrosis (MMM) or acute leukaemia (AL). There is an ongoing debate whether the evolution to AL is part of the natural history of the disease or may be related to the use of cytoreductive agents given to control myeloproliferation. It is very likely a combination of intrinsic factors, bound to PV itself, and extrinisic factors, the drugs, may exert a role.

Supporting Agencies


Barbui, T. (2009). Acute leukemia in polycythemia vera. Hematology Meeting Reports (formerly Haematologica Reports), 2(15). https://doi.org/10.4081/hmr.v2i15.608

Downloads

Citations